Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS ' EQUITY (Unaudited)

v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS ' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 8 $ 0 $ 0 $ 232,550 $ (1,374,413) $ (1,141,855)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 1,937,500      
Proceeds from WeFunder offering, net of issuance costs of $53,500 2,205,440 2,205,440
Issuance of Series A preferred stock, net of issuance costs of $205,470 $ 4 2,464,504 2,464,508
Issuance of Series A preferred stock, shares 79,750 415,287        
Conversion of WeFunder offering to Series A preferred stock $ 4 (4)
Conversion of WeFunder Offering to Series A Preferred Stock, shares   351,832        
Conversion of SAFE Liability to Series A preferred stock $ 4 1,999,996 2,000,000
Conversion of SAFE Liability to Series A preferred stock, shares   424,269        
Issuance of Series B preferred stock, net of issuance costs of $890,026 $ 11 9,615,320 9,615,331
Issuance of Series B preferred stock, shares 123,296   1,105,827      
Issuance of common stock with promissory notes, net of issuance costs of $65,000 $ 3 734,997   735,000
[custom:StockIssuedDuringPeriodValueNewIssuesWithPromissoryNotesShares] 266,664          
Stock-based compensation   14,256,318 14,256,318
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture 162,507          
Net loss (25,345,840) (25,345,840)
Ending balance, value at Sep. 30, 2021 $ 13 $ 12 $ 11 31,509,121 (26,720,253) 4,788,904
Shares, Outstanding, Ending Balance at Sep. 30, 2021 2,569,717 1,191,388 1,105,827      
Beginning balance, value at Dec. 31, 2021 $ 128 $ 0 $ 0 47,803,643 (41,499,522) 6,304,249
Shares, Outstanding, Beginning Balance at Dec. 31, 2021 17,309,187 0 0      
Issuance of common stock for public offering, net of issuance costs of $1,910,816 $ 67 18,089,117 18,089,184
Stock Issued During Period, Shares, New Issues 6,666,667          
Issuance of common stock for cashless exercise of warrants
Issuance of common stock for exercise of stock options and restricted shares, shares 240,107          
Stock Issued During Period, Shares, Conversion of Convertible Securities 83,552          
Issuance of common stock for exercise of stock options and restricted shares $ 2 39,998 40,000
Stock-based compensation $ 1 2,642,138 2,642,139
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture 54,623          
Forfeiture of performance shares
[custom:ForfeitureOfPerformanceSharesShares] (2,876)          
Issuance of Note Warrants and underwriter warrants, net of issuance costs of $1,003,513 7,177,976 7,177,976
Net loss (26,437,991) (26,437,991)
Ending balance, value at Sep. 30, 2022 $ 198 $ 0 $ 0 $ 75,752,872 $ (67,937,513) $ 7,815,557
Shares, Outstanding, Ending Balance at Sep. 30, 2022 24,351,260